Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Rheumatology|November 18, 2017
Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI)Janet E Pope, Emmanouil Rampakakis, Mohammad Movahedi, et al.
RMD Open|November 30, 2018
ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)Janet E Pope, Mohammad Movahedi, Emmanouil Rampakakis, et al.
Current Rheumatology Reviews|December 14, 2020
Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative DatabaseElliot Hepworth, Mohammad Movahedi, Emmanouil Rampakakis, et al.
Annals of Surgery|August 21, 2004
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patientsNicolas V Christou, John S Sampalis, Moishe Liberman, et al.
Annals of Plastic Surgery|November 30, 2007
Outcomes in the management of sternal dehiscence by plastic surgery: a ten-year review in one university centerGenevieve Landes, Patrick G Harris, John S Sampalis, et al.
Annals of Surgery|February 28, 2009
Assessment of mortality in older trauma patients sustaining injuries from falls or motor vehicle collisions treated in regional level I trauma centersJohn S Sampalis, Robin Nathanson, Julie Vaillancourt, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 30, 2010
Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertensionCindy Hutnik, David Neima, Fahim Ibrahim, et al.
Rheumatology and Therapy|April 13, 2026
Effectiveness and Safety of Tofacitinib Up to 36 Months in Canadian Patients with Rheumatoid Arthritis: Final Results from the CANTORAL StudyBoulos Haraoui, Denis Choquette, Cristina Sciortino, et al.
Advances in Rheumatology (London, England)|June 24, 2026
CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-worldJanet E Pope, John S Sampalis, Boulos Haraoui, et al.
The Journal of Rheumatology|July 3, 2019
Toward Defining Primary and Secondary Nonresponse in Rheumatoid Arthritis Patients Treated with Anti-TNF: Results from the BioTRAC and OBRI RegistriesEdward C Keystone, Emmanouil Rampakakis, Mohammad Movahedi, et al.
Pageof 10